{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"105.600","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"208,581,239","primaryexch":"香港交易所","ric":"9995.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BMC6XV1","am":"588.89","iv":"","ew_strike":"","as":"102.100","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"102.000","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"500","update_time":"2025-09-28 00:06:03.0","lo52":"10.500","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"王威東","underlying_ric":"688331.SS","hi52":"115.400","issuer_name":"榮昌生物製藥(煙台)股份有限公司 - H股","h_share_flag":true,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"99.000","mkt_cap":"21.27","f_aum_hkd":null,"ew_sub_per_to":"","ls":"102.000","nav_date":"","csic_classification":"醫藥衛生","floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-5.000","aum":"","issued_shares_class_B":null,"vo":"5.77","secondary_listing_flag":false,"listing_date":"2020年11月9日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"榮昌生物製藥(煙台)股份有限公司 - H股","nm_s":"榮昌生物","sym":"9995","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.100","strike_price":"","summary":"榮昌生物製藥（煙臺）股份有限公司是一家主要從事生物醫藥研究、生物醫藥服務及生物醫藥生產和銷售的中國公司。該公司專註於抗體藥物偶聯物（ADC）、抗體融合蛋白、單抗及雙抗等治療性抗體藥物領域。該公司的主要產品包括泰它西普、維迪西妥單抗、RC28-E等。該公司的產品主要應用於自身免疫疾病、腫瘤疾病、眼科疾病等重大疾病領域。該公司主要在中國國內和海外市場開展業務。","op":"105.600","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國<br/>山東省自由貿易試驗區煙台片區<br/>煙台開發區<br/>北京中路58號","pc":"-4.67","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"107.000","isin":"CNE1000048G6","moneyness":""}},"qid":"1759074014402"}
